Personal details

Muhammad C. - Remote

Muhammad C.

Timezone: Seoul (UTC+9)

Summary

Currently I am enrolled in a Doctoral Program (Biomedical Engineering) at Asan Medical Center Ulsan University, Seoul Korea. My previous experience includes working as a research Lecturer at Institute of Space Technology, Islamabad Pakistan. I hold Master of Engineering Degree in Computer Engineering from Jeju National University. Prior to this I served at software engineer at FAST National University before my graduation in Computer Science. I believe that I am excellent researcher, programmer based on my background and achievement that I have made to date. During my studies I mainly studies following areas in computer science, Network Data Mining, Knowledge Discovery, Predictive Analytics, Semantic Web Technologies and Computer Networks.

Work Experience

Research Student
Gachon Institute of Genome Medicine and Sciences | Jan 2016 - Present
Python
Java
Machine Learning
Data Science
Currently, I am working as a research student at Gachon Institute of Genome Medicine and Sciences. I am actively involved in research related to integration of biological databases and cancer generics. Focus of my work is to perform Data Science tasks on biological data to extract insights from massive amount of biological heterogeneous data. Biological Data Integration Genomic Data Analysis Biological Information Networks
Research Lecturer
Institute of Space Technology (IST) | Jan 2014 - Mar 2015
Java
Python 3
My responsibility to conduct innovated research and supervise Undergraduate Students. As Research Lecturer I have been actively involved in research related to predictive analytics and Cyber Security. In particular, I developed a secured communication platform using our customized encryption algorithm. Along with this, I have been working on text analysis and text classification problem using different Machine Algorithm algorithms. My this job give me chance to explore Machine Learning algorithm and libraries.

Personal Projects

cMapper: gene-centric connectivity mapper for EBI-RDF platformIconOpenNewWindows
2016
Java
MySQL
Big Data
cMapper allows biologists to interrogate data points in the EBI-RDF platform that are connected to genes or small molecules of interest in multiple biological contexts. Input to cMapper consists of a set of genes or small molecules, and the output is the data points in six independent EBI-RDF databases connected with the given genes or small molecules in the user's query. cMapper pro-vides output to users in the form of a graph in which nodes represent data points and the edges represent connections between data points and inputted sets of genes or small molecules. Users can also apply filters based on database, taxonomy, organ and pathways in order to focus on a core connectivity graph of their interests.
Deep Learning for Drug Prediction using Gene Expression Data
2018
Python 3
Keras
In this project, we designed a deep learning framework to predict drug response using gene expression data. Our Drug Prediction framework consists of following three different stages (1) pre-processing, (2) feature selection and (3) model fitting. The pre-processing phase gene expression values were normalized to avoid from biasness using min-max transformation which alighted the data points between 0 and 1. Since it was not clear to us that which features selection method would perform better therefore we performed an evaluation test using Principle Component Analysis, Mutual Information, Differential Expression Analysis, and Chi Squires test. We designed and tested deep neural networks with multiple architectures in term of number of hidden layers and number of neurons in each layer. We perform experiments for 2, 4, 8, 16 hidden layers. DNN was designed using Keras (A python Library) and performance was measured using scikit learn The performance of DNN archticutres was analyzed based on Learning Rate and Accracy. The developed deep neural network to predicted drug response of five cancer drugs with more 95% accuracy and predict drug targets of 9 drugs with more than 90% accuracy using the gene expression data.